This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Randall Lipps Chairman, President, CEO, and Founder, Omnicell Today, I was excited to join thousands of registrants representing pharmacy, nursing, informatics, and healthcare leaders for the launch of Omnicell Illuminate 2020 , one of the year’s biggest digital events dedicated to technology-driven medication management.
Carol Kimura VP, Brand, Digital and Growth Marketing, Omnicell A year ago, we couldn’t have imagined the trials 2020 would bring to healthcare, yet health system pharmacists have risen to the challenge. Discover how you can start your journey to zero-error medication management.
Ken Osborn Senior Director, Product Marketing, Omnicell Latest Innovation in Winter 2020 Release Advances Journey to the Autonomous Pharmacy The need for solutions designed to help customers achieve greater visibility, control costs, and better manage an increasingly complex pharmacy supply chain is more important than ever.
Carol Kimura VP, Brand, Digital and Growth Marketing, Omnicell This week, thousands of attendees from across Pharmacy, Nursing, Finance, IT, and Leadership joined Omnicell and their peers for Omnicell Illuminate 2020 – the biggest digital event for technology-driven pharmacy supply chain.
Scott Seidelmann EVP and Chief Commercial Officer, Omnicell As COVID-19 continues to impact healthcare across the care continuum, the need for solutions designed to help providers achieve greater visibility, control costs, and better manage an increasingly complex pharmacy supply chain is more important than ever.
Over 20 months from February 2020 to September 2021, healthcare lost an astounding 525,000 workers. The Omnicell Blog is the leading source for pharmacy care, exploring emerging trends, successful best practices, and ideas and insights focused on the digital transformation of pharmacy.
Jim Garretson VP, Platform & Omnicell One, Omnicell Can you imagine having improved visibility across your pharmacy operation? 10, for a session titled, “From Seeing to Believing: Going Beyond Data to Prescriptive Actions and Closed Loop Workflows” as part of Omnicell Illuminate 2020.
Mary Selzo, RPh Practicing Pharmacist and Senior Clinical Product Manager, Omnicell The operating room is one of the most intense and dynamic environments in any health system. Omnicell’s automated dispensing technology is saving up to 20 percent of time spent at the cabinet through new waste workflows (based on Omnicell customer data).
During our Omnicell Illuminate 2020 presentation “Streamlining Use of Technology at the Point of Care,” Nish Parekh, Vice President of Point of Care Solutions at Omnicell, and I explored how cloud-based solutions are getting us closer to the goal of zero-error medication management. One word: cloud.
Director Central Pharmacy Product Marketing at Omnicell In many other industries we’ve seen success in how technology is accelerating and transforming the way products and services are created, delivered, consumed, and measured. Dennis Wright, Sr.
Tanja Portmann VP of Professional Services, Omnicell When it comes to digital transformation and implementation of new technology, change can be good, especially when that change is managed by a supporting, trusted technology partner.
Terri Albarano, PharmD Director, Autonomous Pharmacy, Omnicell Sterile compounding safety is one of the biggest challenges for the pharmacy supply chain. An ISMP Pulse Check of Sterile Compounding Practices” as part of Omnicell Illuminate 2020. Injectable medications cause 1.2 billion in associated costs.
Jim Stevenson, PharmD Vice President, Medication Systems Strategy, Omnicell The autonomous pharmacy is a bold new vision for the future of medication management that aims to replace manual, error-prone activities with automated interoperable processes that are safer and more efficient.
Joy Somogyi Senior Director of Product Marketing and Development, Omnicell With two million people suffering from opioid addiction and 115 people dying from an opioid overdose every day in the U.S., the opioid crisis is one of the major challenges healthcare is facing, specifically for pharmacies currently managing medication diversion.
Michael Korthuis VP of Engineering, Omnicell Data intelligence is nothing new to healthcare. Register today to discover the future of pharmacy at Omnicell Illuminate 2020 and explore our three-day slate of continuing education, networking, interactive demos, and more learning opportunities.
Register today to discover the future of pharmacy at Omnicell Illuminate 2020 and explore our three-day slate of continuing education, networking, interactive demos, and more learning opportunities. I’ll also be sharing my personal experiences addressing and managing diversion in my role at Texas Children’s.
Lani Bertrand, RPh Senior Director, Clinical Consulting, Omnicell It’s more challenging than ever to effectively manage the distribution of medications across the health system. 9, for the CE-accredited session “Key Considerations for a System-Wide Medication Management Strategy,” as part of Omnicell Illuminate 2020.
Juliana Linsdell Nurse Consultant, Omnicell Nursing is a healthcare profession that represents the cross section of art and science, heart and mind, and the ability to balance rigorous treatment standards with the subjective experience of a patient’s physical and emotional needs.
That’s why I was excited to share our experiences, and the safety advantage of IV workflow and robotics in producing safe and cost effective IV preparations, during the Omnicell Illuminate 2020 session, “Driving Safety and Savings Through System-Wide Sterile Compounding Automation.”
Jeff Spencer Senior Director, Sales and Account Management, Omnicell For more than 25 years, the 340B Drug Pricing Program has provided financial assistance to eligible hospitals and other healthcare facilities serving vulnerable communities.
Mike Cantrell Senior Director, Regional Operations, EnlivenHealth™, an Omnicell Innovation Given the continuing effects of the COVID-19 pandemic, pharmacists are playing an increasingly important role in providing trusted, accessible and affordable healthcare.
Ken Perez Vice President of Healthcare Policy, Omnicell; In Sept. 2020, the U.S. Please visit Omnicell's Webinars to learn more about 340B and other healthcare topics. Add link to Omnicell's Webinars. Census Bureau announced that the number of Americans in poverty in 2019 was 34 million, about 10.5
2020: After being sued once again by 340B providers, HRSA established the Administrative Dispute Resolution program. 2020: Eli Lilly became the first drug manufacturer to announce restrictions on access to 340B pricing in the contract pharmacy setting. Questions persist about its effectiveness.
In January 2020, the Ohio State Board of Pharmacy approved a check waiver for Summa Health after we demonstrated an accuracy rate exceeding 99.8%, with zero incorrect medications picked for 95,793 doses. One of the most exciting features of XR2 is the dispensing accuracy.
Bureau of Labor Statistics reports that healthcare lost 524,000 employees – about 4 percent of its workforce – between February 2020 and September 2021. On a rolling 12-month time frame, more than 19 percent of post-acute discharges during the fourth quarter of 2020 were to nursing homes, according to Trella Health's research.
Bureau of Labor Statistics reports that healthcare lost 524,000 employees – about 4 percent of its workforce – between February 2020 and September 2021. On a rolling 12-month time frame, more than 19 percent of post-acute discharges during the fourth quarter of 2020 were to nursing homes, according to Trella Health's research.
In fact, in a 2020 ISMP Sterile Compounding Pulse Check conducted with 634 pharmacy practitioners, only 25% of respondents report using technologies that include barcode verification, images, and gravimetric verification for 50% of compounded sterile products.
Lisa Armburger Director, Client Success Executive, Omnicell 340B The pressures of the last year have underscored the importance of the 340B program and its impact on hospital finances. In light of the bold contract pharmacy actions of 2020, this is an area that is becoming more critical.
The Omnicell Blog is the leading source for pharmacy care, exploring emerging trends, successful best practices, and ideas and insights focused on the digital transformation of pharmacy. Supreme Court decision that ruled that states can regulate PBM behavior. Whether we will see a resolution before the November elections remains uncertain.
Ken Perez Vice President of Healthcare Policy and Government Affairs at Omnicell All About Herd Immunity You’ve probably heard the term “herd immunity” debated and discussed in the news. The Centers for Disease Control and Prevention (CDC) estimates that at the end of December 2020, 83.1
As Emily Cook of McDermott Will & Emery pointed out, CMS did not conduct its survey of 340B acquisition costs until after the 2020 payment cuts went into effect. Impacted hospitals may need to conduct a similar review for 2020-present claims at some point soon.” ” Stay tuned for more action in this fascinating drama.
In December 2020, HRSA finalized the long-anticipated ADR rule. It will be critical for the government to incorporate these scenarios and ensure covered entities are made whole for the financial losses incurred during the duration of the manufacturers’ non-compliance.
Ken Perez VP of Healthcare Policy Omnicell The Democrats’ recent sweep of the United States Senate Georgia runoff elections means the Democrats will control both chambers of Congress as well as the White House for the first time since 2010.
Regardless of the outcome of the 2020 general elections, strong bipartisan support for the 340B program is expected to continue just as it has throughout the program’s nearly 30-year history. For more information on the programs history and a digestable synopsis of the 340B program explained , visit our blog!
In 2020, the agency stated on several occasions, including to 340B Report , that it did not have the legal authority to enforce the contract program and compel manufacturers to provide 340B discounts dispensed by contract pharmacies. The agency's position changed starting in late 2020.
In September 2020 , he signed a Senate Democratic letter to Pharmaceutical Research and Manufacturers of America’s (PhRMA) President expressing “deep concern” over drug manufacturers’ denials or impositions of conditions on 340B pricing on drugs dispensed by contract pharmacies.
Ken Perez Vice President of Healthcare Policy, Omnicell The United States spends much more on healthcare on a per capita basis than other high-income countries, due in large part to the high cost of prescription drugs, and polls consistently show that high drug costs are the number one healthcare issue for Americans.
Ken Perez Vice President, Healthcare Policy and Government Affairs, Omnicell How much health policy change can the Biden administration effect during the next four years? 10, 2020, the Supreme Court heard oral arguments over the constitutionality of the Affordable Care Act (ACA). and Senate Minority Leader Mitch McConnell (R-Ky.)
We organize all of the trending information in your field so you don't have to. Join 5,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content